Skip to content

RYTMRHYTHM PHARMACEUTICALS INC

CUSIP 76243J105 · common stock

8 tracked investors held RHYTHM PHARMACEUTICALS INC (RYTM) at the end of Q3 2026, worth $1.8B in total. The largest holder was RA Capital Management, with 6.4% of its portfolio. Ken Fisher opened a new position this quarter.

Holders · Q3 2026
8
New holders
1
Value held
$1.8B
Quarter-end price (est.)
$95.22

Investors holding RYTM · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
6.37%6,666,837$634.8MHOLD
Julian Baker
Baker Bros. Advisors LP
2.54%5,604,483$533.6MHOLD
PRIMECAP Management
PRIMECAP Management Co
0.18%3,064,317$291.8MREDUCE-3.3%
Perceptive Advisors
Perceptive Advisors LLC
4.20%2,532,556$241.1MREDUCE-2.1%
Stanley Druckenmiller
Duquesne Family Office LLC
0.57%269,900$25.7MADD+32.6%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.56%138,658$13.2MADD+1.8%
Ken Fisher
Fisher Asset Management, LLC
0.00%105,999$10.1MNEW
Joel Greenblatt
Gotham Asset Management, LLC
0.00%5,107$486.3KREDUCE-7.4%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026810$1.8B$95.22
Q2 2026710$2B$111.03
Q1 2026600$1.6B$86.97
Q4 2025600$2B$107.04